# APIXABAN
> **ANDA210133** · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON PHARMA INC · Approved 2022-04-12
## Drug
- **FDA Application Number:** ANDA210133
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** APIXABAN
- **Generic name:** Apixaban
- **Active ingredients:** APIXABAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** PRINSTON PHARMA INC
- **First approval:** 2022-04-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210133)
---
*MORVS · CC0 1.0*